Annual report [Section 13 and 15(d), not S-K Item 405]

Shareholders' Equity and Capital Stock - Additional Disclosure (Details)

v3.25.1
Shareholders' Equity and Capital Stock - Additional Disclosure (Details)
$ / shares in Units, $ in Thousands
 1 Months Ended 12 Months Ended
Jul. 29, 2024
USD ($)
$ / shares
shares
Feb. 28, 2023
shares
Feb. 21, 2023
USD ($)
$ / shares
shares
Feb. 28, 2021
$ / shares
shares
Dec. 31, 2024
USD ($)
$ / shares
shares
Dec. 31, 2023
USD ($)
shares
Dec. 31, 2024
$ / shares
May 29, 2020
USD ($)
Shareholders Equity and Capital Stock                
Common share outstanding | shares         364,101,038 270,898,900    
Common share issued | shares         364,101,038 270,898,900    
Shares issued upon public offering | shares 57,150,000   34,000,000          
Warrants to purchase | shares     17,000,000          
Public offering price per share | $ / shares $ 1.05   $ 1.18          
Exercise price | $ / shares     $ 1.5          
Class of warrant or right, expiry term     3 years          
Period of option to purchase additional shares by underwriter 30 days   30 days          
Additional common shares purchase | shares 8,572,500   5,100,000          
Additional warrants purchase | shares     2,550,000          
Warrants issued to purchase common shares | shares 65,722,500              
Purchase warrants | shares     19,550,000   19,520,500      
Gross proceeds with warrants $ 69,000   $ 46,100          
Fees and expenses 3,800   3,000          
Net proceeds from offerings 65,200   $ 43,100          
Net proceeds from common stock issuance         $ 97,568 $ 53,142    
Number of warrants exercised | shares         (16,376,500) (413,030)    
Options exercised         $ 1,300 $ 1,400    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period | shares         2,351,563 2,225,098    
Grants of options, term         3 years      
Service term option         5 years      
Intrinsic value of date of grant | $ / shares         $ 0      
Intrinsic value of options exercised         $ 1,700      
Employee Service Share-based Compensation Period for Recognition         2 years 4 months 24 days      
Closing stock price per share | (per share)         $ 1.15   $ 1.64  
In-the-money stock options outstanding | shares         4,949,351      
In-the-money stock options exercisable | shares         4,191,353      
fair value of RSUs vested         $ 100      
Stock option liabilities         1,758      
US                
Shareholders Equity and Capital Stock                
Stock option liabilities $ 2,500       1,800      
Restricted Stock Units RSU One [Member]                
Shareholders Equity and Capital Stock                
Stock-based compensation expense         500 $ 300    
Unamortized stock based comoensation expenses         $ 1,000      
Employee Service Share-based Compensation Period for Recognition         1 year 8 months 12 days      
Warrants One [Member]                
Shareholders Equity and Capital Stock                
Warrants issued to purchase common shares | shares   39,100,000 39,100,000 16,930,530        
Warrant term   3 years   3 years        
Gross proceeds with warrants         $ 11,100 300    
Common shares purchase | shares     19,550,000 8,465,265        
Share price | $ / shares     $ 1.5 $ 1.35        
Equity Option [Member]                
Shareholders Equity and Capital Stock                
Unamortized stock based comoensation expenses         2,200      
Stock-based compensation expense         $ 800 $ 70    
Common Shares                
Shareholders Equity and Capital Stock                
Warrants issued to purchase common shares | shares         16,939,825 4,425,809    
Common stock shares sold, amount         $ 28,600 $ 7,000    
Common stock issued costs         700 200    
Net proceeds from common stock issuance         27,800 6,800    
Warrants exercised         $ 11,100 $ 300    
Number of warrants exercised | shares         16,376,500 413,030    
Number of warrants exercised for underlying common shares | shares         8,188,250 206,515    
Options exercised         $ 1,300 $ 1,400    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period | shares         2,351,563 2,225,098    
Common shares issued for released RSUs | shares           241,857    
Agents for aggregate sales proceeds               $ 100,000
First anniversary                
Shareholders Equity and Capital Stock                
Percentage of grant option         33.33%      
Second anniversary                
Shareholders Equity and Capital Stock                
Percentage of grant option         33.33%      
Third anniversary                
Shareholders Equity and Capital Stock                
Percentage of grant option         33.33%